Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MonoSol Rx has filed an amended patent infringement and false marking lawsuit against BioDelivery Sciences International (BDSI), MEDA Pharmaceuticals and Aveva Drug Delivery Systems in the US District Court for the District of New Jersey.
Subscribe to our email newsletter
MonoSol Rx’s complained that BDSI, MEDA, and Aveva’s manufacture, marketing, and sale of the Onsolis film products infringe MonoSol Rx’s US patent no 7,824,588 related to methods of making drug-containing films.
MonoSol Rx has filed its patent infringement claim against these defendants initially in November, 2010.
The current amended complaint is additional false marking claims with respect to US patent no 5,800,832.